AZITHROMYCIN FOR INJECTION, USP
EUGIA PHARMA INC.
Quick answers
Is there a shortage of AZITHROMYCIN FOR INJECTION, USP in Canada?
No. There is no current shortage of AZITHROMYCIN FOR INJECTION, USP 500MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AZITHROMYCIN FOR INJECTION, USP
AURO PHARMA INC
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02531429
Strength
500MG
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE)
See all AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from EUGIA PHARMA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MG · DIN 02531224
500MG · DIN 02530481
2G · DIN 02530511
1G · DIN 02530503
25MG · DIN 02541998
100MG · DIN 02542005
500MG · DIN 02541920
100MCG · DIN 02528886
1G · DIN 02537176
2MG · DIN 02544830
2MG · DIN 02544822
10MG · DIN 02498820